We are live on ! Find out more
WS

Wedbush Securities Portfolio holdings

AUM $3.43B
1-Year Est. Return 24.13%
This Fund
S&P 500
This Quarter Est. Return
+7.52%
1 Year Est. Return
+24.13%
3 Year Est. Return
+79.76%
5 Year Est. Return
+94.69%
10 Year Est. Return
+325.94%
AUM
$1.13B
AUM Growth
+$103M
Cap. Flow
+$30.2M
Cap. Flow %
2.68%
Top 10 Hldgs %
16.52%
Holding
1,066
New
90
Increased
448
Reduced
352
Closed
73

Top Buys

Rank Stock Value
1
MINT icon
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
+$2.37M
2
XOM icon
ExxonMobil
XOM
+$1.94M
3
CMCT
Creative Media & Community Trust
CMCT
+$1.78M
4
CRON
Cronos Group
CRON
+$1.63M
5
TIP icon
iShares TIPS Bond ETF
TIP
+$1.57M

Top Sells

Rank Stock Value
1
PAR icon
PAR Technology
PAR
+$3.9M
2
IEF icon
iShares 7-10 Year Treasury Bond ETF
IEF
+$1.92M
3
SPSB icon
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
+$1.59M
4
EEI
Ecology and Environment
EEI
+$1.58M
5
SHV icon
iShares 0-1 Year Treasury Bond ETF
SHV
+$1.31M

Sector Composition

Rank Sector Weight
1 Technology 13.45%
2 Healthcare 9.16%
3 Financials 8.86%
4 Consumer Discretionary 7.96%
5 Industrials 6.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DSE
951
DELISTED
Duff & Phelps Select MLP and Midstream Energy Fund Inc.
DSE
$40K ﹤0.01%
1,043
-200
-16% -$7.63K
GNCA
952
DELISTED
Genocea Biosciences, Inc.
GNCA
$40K ﹤0.01%
+19,100
New +$45.3K
FTFT icon
953
Future FinTech Group
FTFT
$2.2M
$37K ﹤0.01%
104
+51
+96% +$24.7K
CGRN
954
DELISTED
Capstone Green Energy Corporation Common Stock
CGRN
$37K ﹤0.01%
11,965
-34,395
-74% -$116K
CYTO
955
DELISTED
Altamira Therapeutics Ltd
CYTO
$36K ﹤0.01%
+55
New +$37.3K
SPHS
956
DELISTED
Sophiris Bio, Inc.
SPHS
$33K ﹤0.01%
+90,000
New +$40.9K
CRDF icon
957
Cardiff Oncology
CRDF
$64.3M
$32K ﹤0.01%
25,907
+12,337
+91% +$17.6K
ACGN
958
DELISTED
Aceragen Inc
ACGN
$30K ﹤0.01%
+966
New +$35.9K
EFOI icon
959
Energy Focus
EFOI
$18.3M
$28K ﹤0.01%
1,714
-29
-2% -$448
VBIV
960
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$28K ﹤0.01%
+667
New +$14.6K
NBRV
961
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$25K ﹤0.01%
76
-29
-28% -$13.3K
COGT icon
962
Cogent Biosciences
COGT
$6.79B
$24K ﹤0.01%
8,284
– –
NBEV
963
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
$23K ﹤0.01%
12,700
– –
CHK
964
DELISTED
Chesapeake Energy Corporation
CHK
$21K ﹤0.01%
129
– –
RGLS
965
DELISTED
Regulus Therapeutics
RGLS
$19K ﹤0.01%
2,086
-2,031
-49% -$14.1K
GPUS
966
Hyperscale Data Inc
GPUS
$57.8M
– –
0
– –
IDXG
967
DELISTED
Interpace Biosciences, Inc. Common Stock
IDXG
$13K ﹤0.01%
+2,661
New +$17.2K
TTOO
968
DELISTED
T2 Biosystems, Inc
TTOO
$12K ﹤0.01%
+2
New +$18.9K
AVEO
969
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$12K ﹤0.01%
+2,000
New +$14.7K
SITO
970
DELISTED
SITO MOBILE, LTD
SITO
$11K ﹤0.01%
40,000
-10,000
-20% -$5.26K
LKSD
971
DELISTED
LSC Communications, Inc.
LKSD
$7K ﹤0.01%
33,260
-7,420
-18% -$5.64K
PLM
972
DELISTED
PolyMet Mining Corp.
PLM
$3K ﹤0.01%
1,150
– –
ATNM icon
973
Actinium Pharmaceuticals
ATNM
$27M
$2K ﹤0.01%
333
– –
ARDX icon
974
Ardelyx
ARDX
$1.24B
– –
-29,840
Closed -$140K
ASML icon
975
ASML
ASML
$675B
– –
-1,954
Closed -$485K
37 38
39
40 41

Similar funds

CCM
Check Capital Management Costa Mesa, California $3.44B AUM 9.15% 1-Year Est. Return
SI
Sprott Inc Toronto, Ontario, Canada $3.44B AUM 125.26% 1-Year Est. Return
CIA
Caledonia Investments (Australia) Sydney NSW, Australia $3.44B AUM 20.03% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
PWP
Perfromance Wealth Partners Hinsdale, Illinois $3.45B AUM 29.14% 1-Year Est. Return
RBA
Richard Bernstein Advisors New York $3.45B AUM 16.24% 1-Year Est. Return
PCM
PAR Capital Management Boston, Massachusetts $3.45B AUM 28.5% 1-Year Est. Return
LNC
Lincoln National Corp Radnor, Pennsylvania $3.45B AUM 12.55% 1-Year Est. Return

Wedbush Securities's Q4 2019 Portfolio in Review

As of Q4 2019, Wedbush Securities held 1,066 positions worth $1.13B, up 10% from $1.02B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Wedbush Securities's Q4 2019 filing shows 90 new, 448 increased, 352 reduced and 73 closed positions. Its largest new stake was PIMCO Enhanced Short Maturity Active Exchange-Traded Fund: 23,273 shares worth $2.36M. The largest sale was PAR Technology, an estimated $3.9M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Healthcare and Financials.

  • Wedbush Securities's largest Q4 2019 buy was PIMCO Enhanced Short Maturity Active Exchange-Traded Fund: 23,273 shares worth $2.36M.
  • Wedbush Securities added most to ExxonMobil in Q4 2019, an estimated $1.94M increase.
  • Wedbush Securities's biggest Q4 2019 reduction was PAR Technology, cutting an estimated $3.9M.
  • Wedbush Securities fully exited State Street SPDR Portfolio Short Term Corporate Bond ETF in Q4 2019, selling an estimated $1.59M.
  • Wedbush Securities's ten largest holdings make up 17% of its $1.13B portfolio in Q4 2019.
  • Wedbush Securities opened 90 new positions and closed 73 in Q4 2019.
  • Wedbush Securities's portfolio value rose 10% quarter-over-quarter to $1.13B.

Based on Wedbush Securities's 13F filing for Q4 2019, filed 16 Jan 2020.